View Annual Report - Jules Stein Eye Institute
View Annual Report - Jules Stein Eye Institute
View Annual Report - Jules Stein Eye Institute
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
Genetics of Age-Related<br />
Maculopathy (GARM II)<br />
The purpose of this study is to identify<br />
the hereditary and exposure risk factors<br />
that lead to the development of<br />
age-related maculopathy (ARM) in<br />
a cohort with a family history of the<br />
disease. The study is intended for<br />
individuals (49 and older) who have<br />
at least one parent with this condition,<br />
the spouses or partners of these<br />
individuals, and the parents themselves.<br />
Investigators: Michael B. Gorin, MD,<br />
PhD; and Maria Carolina Ortube, MD<br />
Heavy Metals in Surgically<br />
Removed Human Ocular Tissue<br />
Faculty members are examining the<br />
concentration of heavy metals in ocular<br />
tissue compared to blood concentrations.<br />
High volumes of specific heavy<br />
metals in the vitreous have been found<br />
to cause toxicity in the retina. Information<br />
about the concentrations of<br />
heavy metals in common vitreoretinal<br />
diseases could lead to a new physiopathological<br />
approach. Investigators:<br />
Jean-Pierre Hubschman, MD; and<br />
Steven D. Schwartz, MD<br />
Incidence of Late Macular<br />
Degeneration in Older Women<br />
The goal of this research is to determine<br />
the incidence of late age-related<br />
macular degeneration (AMD), the<br />
rate of progression of AMD, and the<br />
association of specific risk factors such<br />
as diabetes mellitus and prior cataract<br />
surgery with late AMD and its progression<br />
in older women. Investigator: Anne<br />
L. Coleman, MD, PhD<br />
Investigational Drug for Treatment<br />
of Vascular Pigment Epithelial<br />
Detachment (vPED)<br />
The purpose of this study is to see if<br />
the treatment of a vPED, a complication<br />
of macular degeneration, with<br />
ranibizumab is safe and effective<br />
with the regular dose (0.5 mg) or<br />
the high dose (2.0 mg). Investigators:<br />
David Sarraf, MD; and Colin A.<br />
McCannel, MD<br />
Natural History Study of<br />
Macular Telangiectasia<br />
Investigators are collecting data about<br />
macular telangiectasia with the goal<br />
of acquiring more knowledge of and<br />
developing a treatment for this rare<br />
retinal disease. Investigators: Steven<br />
D. Schwartz, MD; Michael B. Gorin, MD,<br />
PhD; Jean-Pierre Hubschman, MD;<br />
Allan E. Kreiger, MD; Tara A. McCannel,<br />
MD, PhD; and David Sarraf, MD<br />
Ocular Hazards from Currently<br />
Available Light Curing Units<br />
The purpose of this study is to assess<br />
the potential of currently available<br />
curing lights to cause retinal damage<br />
to dental personnel, to evaluate the<br />
amount of exposure to curing lights by<br />
dental personnel, and to assess current<br />
levels of retinal degenerative changes<br />
in dental workers that are possibly<br />
induced by curing lights. Investigators:<br />
Jean-Pierre Hubschman, MD; and<br />
Steven D. Schwartz, MD<br />
P200CAF Autofluorescence<br />
Ultra-Widefield Scanning Laser<br />
Ophthalmoscope in Subjects<br />
with Vitreoretinal Disease<br />
This study utilizes an ultra-widefield<br />
scanning laser ophthalmoscope with<br />
autofluorescence (SLO-AF) to take<br />
pictures of the retina in a noninvasive<br />
way. Images acquired with the SLO-AF<br />
are compared with those from other<br />
currently available instruments to evaluate<br />
the potentially improved resolution<br />
for diagnosis of retinal eye diseases.<br />
Investigators: Steven D. Schwartz, MD;<br />
Jean-Pierre Hubschman, MD; Allan<br />
E. Kreiger, MD; and Tara A. McCannel,<br />
MD, PhD<br />
Pars Plana Vitrectomy with and<br />
without ILM Peel<br />
This study is evaluating and comparing<br />
possible differences in the vision, as<br />
well as the thickness and shape of the<br />
back of the eye, following pars plana<br />
vitrectomy surgery with and without<br />
internal limiting membrane peeling in<br />
patients with complications of diabetic<br />
retinopathy. Investigator: Jean-Pierre<br />
Hubschman, MD<br />
Rapid, Noninvasive, Regional<br />
Functional Imaging of the Retina<br />
In this study funded by the NIH,<br />
<strong>Institute</strong> investigators are monitoring<br />
the responses of the pupil to light as a<br />
method for detecting regional losses<br />
of function of the retina. The ultimate<br />
goal of this research is to develop a<br />
simple, noninvasive, rapid method for<br />
widespread screening of diabetics in<br />
order to identify those who may require<br />
medical attention and/or therapy for<br />
diabetic retinopathy. Investigators:<br />
Michael B. Gorin, MD, PhD; and Maria<br />
Carolina Ortube, MD<br />
Resolution of Vitreomacular<br />
Adhesion Associated with<br />
Neovascular Age-Related<br />
Macular Degeneration with<br />
Intravitreal Microplasmin<br />
Faculty members are evaluating the<br />
safety and efficacy of intravitreal injection<br />
of microplasmin on age-related<br />
macular degeneration (AMD) with<br />
focal vitreomacular adhesion (VMA).<br />
Previous research has shown that<br />
intravitreal microplasmin may offer<br />
physicians a safe agent for resolution<br />
of focal VMA in AMD patients<br />
without surgery. Investigators: Steven<br />
D. Schwartz, MD; and Jean-Pierre<br />
Hubschman, MD<br />
Understanding the Genetics of<br />
Inherited <strong>Eye</strong> Disorders<br />
The <strong>Institute</strong> is participating in a study<br />
to search for the gene(s) responsible<br />
for inherited disorders that are either<br />
specific to the eye or have eye findings<br />
as part of the medical condition. This<br />
study provides for the clinical characterization<br />
of affected individuals and<br />
at-risk family members, in conjunction<br />
with molecular genetic testing, to identify<br />
the causative genes and mutations.<br />
Investigators: Anthony J. Aldave, MD;<br />
Michael B. Gorin, MD, PhD; and Maria<br />
Carolina Ortube, MD<br />
Appendices | Clinical Research Studies 109